The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma

2010 ◽  
Vol 46 (2) ◽  
pp. 212-221 ◽  
Author(s):  
Satoru Hagiwara ◽  
Masatoshi Kudo ◽  
Kazuomi Ueshima ◽  
Hobyung Chung ◽  
Mami Yamaguchi ◽  
...  
2009 ◽  
Vol 275 (2) ◽  
pp. 185-193 ◽  
Author(s):  
Alexei V. Salnikov ◽  
Grace Kusumawidjaja ◽  
Vanessa Rausch ◽  
Helge Bruns ◽  
Wolfgang Gross ◽  
...  

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Takayuki Kawai ◽  
Kentaro Yasuchika ◽  
Takamichi Ishii ◽  
Yuya Miyauchi ◽  
Hidenobu Kojima ◽  
...  

Oncotarget ◽  
2016 ◽  
Vol 7 (16) ◽  
pp. 21644-21657 ◽  
Author(s):  
Phyllis F.Y. Cheung ◽  
Tan To Cheung ◽  
Chi Wai Yip ◽  
Linda W.C. Ng ◽  
Sze Wai Fung ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document